Critical assessment of thioguanine treatment for Inflammatory Bowel Diseases: is it time to rehabilitate this treatment?

CONCLUSIONThe evidence to support thioguanine treatment is limited to observational studies. While encouraging, there is a need for prospective randomised controlled trials to determine the place of thioguanine in the management of inflammatory bowel disease. Copyright © 2017 John Wiley & Sons, Ltd.

Source: Journal of Digestive Diseases - June 1, 2017 Category: Gastroenterology Authors: Ramya Movva, Alison Haywood, Sohil A Khan, Timothy H J Florin, Iulia Oancea Tags: Original article Source Type: research